{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:22:49Z","timestamp":1780122169739,"version":"3.54.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The global burden of non-alcoholic steatohepatitis (NASH)-related liver cancer (NRLC) is increasing, making NASH the fastest-growing cause of liver cancer worldwide. This study presents a comprehensive analysis of NRLC burden at the global, regional, and national levels, further categorized by age, sex, and sociodemographic index (SDI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Data on NRLC from the Global Burden of Disease, Injuries, and Risk Factors (GBD) study 2021 were downloaded at global, regional, and national levels. The numbers and age-standardized rates (ASRs) of incidence, mortality, and disability-adjusted life years (DALYs) were analyzed to quantify the global burden of NRLC. Additionally, percentage changes in ASRs were used to identify trends in NRLC from 1990 to 2021.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Globally, both the number of cases and ASRs for NRLC increased between 1990 and 2021. In 2021, there were 42,291 new cases, 40,925 deaths, and 995,475 DALYs attributed to NRLC. East Asia, South Asia, and Southeast Asia reported the highest absolute case numbers, while Western, Southern, and Eastern Sub-Saharan Africa exhibited the highest ASRs. From 1990 to 2021, Australasia, Southern Latin America, and High-income North America showed the most significant increases in NRLC incidence. Nationally, Mongolia, Gambia, and Mozambique exhibited the highest ASR in 2021.The greatest percentage increases in ASIR occurred in Australia, the United Kingdom, and New Zealand between 1990 and 2021. NRLC incidence rates were higher in men and increased with age, peaking at 80\u201389\u202fyears. Similar patterns were observed for NRLC-related deaths and DALYs. Regionally, ASRs initially declined but then increased as SDI rose. At the national level, ASRs consistently decreased with higher SDI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study highlights the substantial burden of NRLC at global, regional, and national levels. Males and older individuals bear a higher disease burden, and considerable variation exists across different regions and countries. These findings provide critical insights for formulating effective strategies to prevent and manage NRLC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2025.1510563","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T05:14:42Z","timestamp":1737954882000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Burden of NASH related liver cancer from 1990 to 2021 at the global, regional, and national levels"],"prefix":"10.3389","volume":"12","author":[{"given":"Shuang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangjiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjing","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangdong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","article-title":"Global burden of 5 major types of gastrointestinal Cancer","volume":"159","author":"Arnold","year":"2020","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1158\/1078-0432.CCR-18-0847","article-title":"A phase II and biomarker study of Sorafenib combined with modified FOLFOX in patients with advanced hepatocellular carcinoma","volume":"25","author":"Goyal","year":"2019","journal-title":"Clin Cancer Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"188314","DOI":"10.1016\/j.bbcan.2019.188314","article-title":"Challenges in liver cancer and possible treatment approaches","volume":"1873","author":"Anwanwan","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/hep.32758","article-title":"Global burden of liver cancer in males and females: changing etiological basis and the growing contribution of NASH","volume":"77","author":"Tan","year":"2023","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jhep.2023.02.033","article-title":"Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation","volume":"79","author":"Yahoo","year":"2023","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer","volume":"34","author":"Huang","year":"2022","journal-title":"Cell Metab"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","article-title":"The trends in incidence of primary liver cancer caused by specific etiologies: results from the global burden of disease study 2016 and implications for liver cancer prevention","volume":"70","author":"Liu","year":"2019","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/apt.14261","article-title":"Temporal trends, clinical patterns and outcomes of NAFLD -related HCC in patients undergoing liver resection over a 20-year period","volume":"46","author":"Pais","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.18637\/jss.v106.i08","article-title":"Probabilistic estimation and projection of the annual Total fertility rate accounting for past uncertainty: a major update of the bayesTFR R package","volume":"106","author":"Liu","year":"2023","journal-title":"J Stat Softw"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13098-022-00976-w","article-title":"Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990\u20132019: analysis of data from the 2019 global burden of disease study","volume":"15","author":"Li","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-med-090514-013832","article-title":"Liver Cancer: connections with obesity, fatty liver, and cirrhosis","volume":"67","author":"Marengo","year":"2016","journal-title":"Annu Rev Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1470-2045(22)00078-X","article-title":"Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis","volume":"23","author":"Tan","year":"2022","journal-title":"Lancet Oncol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.3390\/biomedicines10102344","article-title":"Inflammasome-mediated cytokines: a key connection between obesity-associated NASH and liver Cancer progression","volume":"10","author":"da Cruz","year":"2022","journal-title":"Biomedicines"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.7869\/tg.120","article-title":"Risk of development of hepatocellular carcinoma in patients with NASH-related cirrhosis","volume":"34","author":"Amarapurkar","year":"2013","journal-title":"Trop Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e0251","DOI":"10.1097\/HC9.0000000000000251","article-title":"The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019","volume":"7","author":"Paik","year":"2023","journal-title":"Hepatol Commun"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13098-022-00885-y","article-title":"Global burden of nonalcoholic steatohepatitis-related liver cancer, 1990\u20132019: a systematic analysis for the GBD 2019","volume":"14","author":"Pang","year":"2022","journal-title":"Diabetol Metab Syndr"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2147\/JHC.S377768","article-title":"Pathogenesis from inflammation to Cancer in NASH-derived HCC","volume":"9","author":"Yu","year":"2022","journal-title":"J Hepatocell Carcinoma"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S1665-2681(19)31354-7","article-title":"Epidemiology of hepatocellular carcinoma in sub-Saharan Africa","volume":"12","author":"Kew","year":"2013","journal-title":"Ann Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/S2468-1253(21)00275-2","article-title":"Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa","volume":"6","author":"Spearman","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S2468-1253(22)00008-5","article-title":"The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas","volume":"7","author":"D\u00edaz","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4254\/wjh.v10.i1.41","article-title":"Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina","volume":"10","author":"Pi\u00f1ero","year":"2018","journal-title":"World J Hepatol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"100359","DOI":"10.1016\/j.aohep.2021.100359","article-title":"NAFLD: challenges and opportunities to address the public health problem in Latin America","volume":"24","author":"Arab","year":"2021","journal-title":"Ann Hepatol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s40471-019-0183-2","article-title":"Environmental risk factors for liver Cancer and nonalcoholic fatty liver disease","volume":"6","author":"VoPham","year":"2019","journal-title":"Curr Epidemiol Rep"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12889-021-12070-3","article-title":"Mongolia health situation: based on the global burden of disease study 2019","volume":"22","author":"Chimed-Ochir","year":"2022","journal-title":"BMC Public Health"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.3390\/nu11122971","article-title":"Mediterranean diet and NAFLD: what we know and questions that still need to be answered","volume":"11","author":"Plaz Torres","year":"2019","journal-title":"Nutrients"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41574-018-0026-0","article-title":"Obesity and the future of food policies that promote healthy diets","volume":"14","author":"Peeters","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/ijo.2016.165","article-title":"Modelling obesity trends in Australia: unravelling the past and predicting the future","volume":"41","author":"Hayes","year":"2017","journal-title":"Int J Obes"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s10198-020-01256-y","article-title":"Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018","volume":"22","author":"Morgan","year":"2021","journal-title":"Eur J Health Econ"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1111\/jgh.15009","article-title":"Nonalcoholic fatty liver disease burden: Australia, 2019-2030","volume":"35","author":"Adams","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4082\/kjfm.20.0165","article-title":"Sedentary lifestyle: overview of updated evidence of potential health risks","volume":"41","author":"Park","year":"2020","journal-title":"Korean J Fam Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1136\/jech-2018-211758","article-title":"Direct healthcare costs of sedentary behaviour in the UK","volume":"73","author":"Heron","year":"2019","journal-title":"J Epidemiol Community Health"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/sj.ijo.0801049","article-title":"Physical inactivity, sedentary lifestyle and obesity in the European Union","volume":"23","author":"Mart\u00ednez-Gonz\u00e1lez","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"9387","DOI":"10.3390\/ijerph18179387","article-title":"Australian school Stakeholders' perceived strategies for preventing adolescent obesity","volume":"18","author":"Buru","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"ref43","article-title":"Physical activity: applying all our health","author":"Whitty","year":"2015","journal-title":"Office for Health Improvement and Disparities"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2318-7-4","article-title":"A snapshot of the prevalence of physical activity amongst older, community dwelling people in Victoria, Australia: patterns across the 'young-old' and 'old-old'","volume":"7","author":"Sims","year":"2007","journal-title":"BMC Geriatr"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"51","author":"Ascha","year":"2010","journal-title":"Hepatology"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13098-022-00930-w","article-title":"Age patterns of nonalcoholic fatty liver disease incidence: heterogeneous associations with metabolic changes","volume":"14","author":"Lin","year":"2022","journal-title":"Diabetol Metab Syndr"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/apt.14352","article-title":"The negative impact of HBV\/HCV coinfection on cirrhosis and its consequences","volume":"46","author":"Pol","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2217\/17455057.5.2.191","article-title":"Nonalcoholic fatty liver disease in women","volume":"5","author":"Suzuki","year":"2009","journal-title":"Women's Health (Lond Engl)"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/j.ejca.2012.02.063","article-title":"Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies","volume":"48","author":"Chen","year":"2012","journal-title":"Eur J Cancer"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1872-034X.2011.00824.x","article-title":"NASH: a global health problem","volume":"41","author":"Sanyal","year":"2011","journal-title":"Hepatol Res"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jhep.2010.07.040","article-title":"Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease","volume":"54","author":"Zein","year":"2011","journal-title":"J Hepatol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.mayocp.2020.07.033","article-title":"Hormonal and metabolic changes of aging and the influence of lifestyle modifications","volume":"96","author":"Pataky","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"729","DOI":"10.21037\/atm-20-4354","article-title":"Non-alcoholic fatty liver disease (NAFLD)\/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention","volume":"9","author":"Tacke","year":"2021","journal-title":"Ann Transl Med"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1007\/s00535-023-02040-4","article-title":"Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis, 1990-2019: a decomposition and age-period-cohort analysis","volume":"58","author":"Liu","year":"2023","journal-title":"J Gastroenterol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1047129","DOI":"10.3389\/fnut.2022.1047129","article-title":"Changes in the global, regional, and national burdens of NAFLD from 1990 to 2019: a systematic analysis of the global burden of disease study 2019","volume":"9","author":"Wang","year":"2022","journal-title":"Front Nutr"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1510563\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T05:14:45Z","timestamp":1737954885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1510563\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":56,"alternative-id":["10.3389\/fnut.2025.1510563"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1510563","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"article-number":"1510563"}}